Haemonetics (HAE) Return on Invested Capital (2010 - 2026)

Haemonetics' Return on Invested Capital history runs 17 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Invested Capital fell 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% decrease from a year earlier, with the FY2026 full-year figure at 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital declined to 0.0% in Q1 2026 per HAE's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.05% in Q4 2024 and bottomed at 0.0% in Q1 2026.
• The 5-year median for Return on Invested Capital is 0.01% (2023), against an average of 0.01%.
• Across the five-year window, Return on Invested Capital climbed 2 bps in 2023 and declined 5 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 0.0% in 2022, then soared by 770 bps to 0.03% in 2023, then soared by 79 bps to 0.05% in 2024, then tumbled by 96 bps to 0.0% in 2025, then plunged by 39 bps to 0.0% in 2026.
• Per Business Quant, the three latest HAE Return on Invested Capital figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).